Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • anspiess
    Junior Member
    • Feb 2015
    • 1

    #1

    Blast versus Tophat

    Hi everyone,

    I noticed that when I download all transcripts of Hg38 genome build from the UCSC Table browser (104178 transcripts, including all splice variants, miRNAs, piRNAs, rRNAs, etc), I can beautifully blast this large fasta file with the 1.3 million 50-mer Illumina RNAseq reads using a standalone blast+ installation. Takes some time but maps ~ 500 reads/sec. Using the corresponding annotation file, I can then annotate all mappings.
    Are there any arguments against this approach, i.e. what are the disadvantages of mapping reads against all transcripts variants versus mapping against the intron-containing complete genome with Tophat.

    Cheers,
    Andrej
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    If you are not interested in finding novel isoforms, splice sites etc you can keep using a "known" transcriptome (and blast).

    As you have discovered, blast is relatively very slow as compared to modern NGS aligners which will map millions of reads.

    BTW: 1.3M reads is a very small NGS dataset

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...